 owners of Purdue Pharma, from legal claims made by opioid victims. In the original settlement, the Sackler family had agreed to pay $6 billion that could be used to settle opioid-related claims, but only in return for a complete release from any liability in future cases. The new ruling means settlement negotiations will restart while the separate Purdue Pharma bankruptcy proceedings continue, which Deputy Attorney General Jason Stabe says could jeopardize Delaware's portion of the funding.